2 Min In News
Follow this topic
Bookmark
Record learning outcomes
Over the past three decades, UK community pharmacy has undergone a profound transformation.
In the mid-1990s, pharmacists were primarily dispensers and advisers, operating in a relatively low-pressure environment with healthy margins. Technology was rudimentary: handwritten prescriptions, limited computers and minimal integration with NHS systems. Clinical engagement was opportunistic rather than structured, and expectations focused on safe medicine supply rather than clinical management.
Fast forward to 2025, and the landscape is almost unrecognisable. Pharmacists are now independent prescribers, managing minor illnesses, long-term conditions and public health interventions. Services such as vaccinations, emergency contraception and blood pressure screening have cemented pharmacy’s role as a front-line healthcare provider.
Electronic prescription services, automation and better skill mix have improved efficiencies. Integration with GP practices and the wider NHS, while still far from perfect, is positioning pharmacists and their teams as true providers of clinical care.
Yet all this comes with significant challenges. Real-term cuts in funding, rising costs and workforce pressures have eroded financial stability and increased stress levels. Business sustainability remains fragile as pharmacy closures, both multiples and independents, show all too clearly.
So has progress been made? Undoubtedly – pharmacy today is far more clinically relevant than it ever was in 1995. But whether the sector is in a better place depends on your perspective: professionally, yes; financially and operationally, almost certainly not.
The next 30 years will demand innovation, resilience and bold leadership if community pharmacy is to thrive as a key pillar of a modern health service.
PS. Check out our 30-year pharmacy retrospective in the October print edition of Pharmacy Magazine! Out soon.
In News